{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:34:59Z","timestamp":1786995299456,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.ophtha.2010.03.063","type":"journal-article","created":{"date-parts":[[2010,7,15]],"date-time":"2010-07-15T05:01:58Z","timestamp":1279170118000},"page":"408-411.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Interferon Alfa-associated Anterior Ischemic Optic Neuropathy"],"prefix":"10.1016","volume":"118","author":[{"given":"F.W.","family":"Fraunfelder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.T.","family":"Fraunfelder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2010.03.063_bib1","first-page":"212","article-title":"Clinical Ocular Toxicology","author":"Fraunfelder","year":"2008"},{"key":"10.1016\/j.ophtha.2010.03.063_bib2","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1001\/archopht.1995.01100080093034","article-title":"Anterior ischemic optic neuropathy secondary to interferon alfa","volume":"113","author":"Purvin","year":"1995","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2010.03.063_bib3","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1002\/hep.23376","article-title":"Results of the IDEAL trial: \u201cMirror, mirror on the wall \u2026 which's the fairest peg-interferon of them all?\u201d","volume":"50","author":"Schulze Zur Wiesch","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.ophtha.2010.03.063_bib4","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1365-2893.2008.00973.x","article-title":"Scientific rationale and study design of the individualized dosing efficacy vs flat dosing to assess optimal pegylated interferon therapy (IDEAL) trial: determining optimal dosing in patients with genotype 1 chronic hepatitis C","volume":"15","author":"McHutchison","year":"2008","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.ophtha.2010.03.063_bib5","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1136\/bjo.82.3.323","article-title":"Interferon associated retinopathy","volume":"82","author":"Hayasaka","year":"1998","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2010.03.063_bib6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2165\/00002018-199410020-00001","article-title":"Harmonisation in pharmacovigilance","volume":"10","author":"Edwards","year":"1994","journal-title":"Drug Saf"},{"key":"10.1016\/j.ophtha.2010.03.063_bib7","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1177\/112067210801800226","article-title":"Hepatitis C virus presumably associated bilateral consecutive anterior ischemic optic neuropathy","volume":"18","author":"Fodor","year":"2008","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.ophtha.2010.03.063_bib8","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1159\/000070195","article-title":"Bilateral optic ischemic neuropathy related to chronic hepatitis C-associated anticardiolipin antibodies","volume":"49","author":"Sinnreich","year":"2003","journal-title":"Eur Neurol"},{"key":"10.1016\/j.ophtha.2010.03.063_bib9","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1001\/archopht.1993.01090030068041","article-title":"Interferon-associated retinopathy","volume":"111","author":"Guyer","year":"1993","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2010.03.063_bib10","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1126\/science.6154315","article-title":"Inhibition of cell motility by interferon","volume":"208","author":"Brouty-Boye","year":"1980","journal-title":"Science"},{"key":"10.1016\/j.ophtha.2010.03.063_bib11","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/cncr.10775","article-title":"Immunomodulatory effects of high-dose and low-dose interferon alpha2b in patients with high-risk resected melanoma: the E2690 laboratory corollary of Intergroup Adjuvant Trial E1690","volume":"95","author":"Kirkwood","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.ophtha.2010.03.063_bib12","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0002-9394(14)70067-4","article-title":"Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders","volume":"117","author":"Hayreh","year":"1994","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2010.03.063_bib13","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1159\/000027450","article-title":"Natural interferon therapy: optic nerve ischemic damage?","volume":"213","author":"Norcia","year":"1999","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.ophtha.2010.03.063_bib14","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0002-9343(02)01102-6","article-title":"Anterior ischemic optic neuropathy caused by interferon alpha therapy [letter]","volume":"112","author":"Gupta","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.ophtha.2010.03.063_bib15","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1076\/ocii.10.4.299.15588","article-title":"Multiple sclerosis-like disease secondary to alpha interferon","volume":"10","author":"Matsuo","year":"2002","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.ophtha.2010.03.063_bib16","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1055\/s-2004-813607","article-title":"Bilateral AION after the combined therapy of hepatitis C with PGE-interferon alpha2B and ribavirin [in German]","volume":"221","author":"Kirchhoff","year":"2004","journal-title":"Klin Monbl Augenheilkd"},{"key":"10.1016\/j.ophtha.2010.03.063_bib17","first-page":"689","article-title":"Sarcoidosis, myasthenia gravis and anterior ischemic optic neuropathy: severe side effects of adjuvant interferon-alpha-therapy in malignant melanoma [in German]?","volume":"2","author":"Kreutzer","year":"2004","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.ophtha.2010.03.063_bib18","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.3748\/wjg.v13.i22.3137","article-title":"Intraocular complications of IFN-alpha and ribavirin therapy in patients with chronic viral hepatitis C","volume":"13","author":"Sene","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ophtha.2010.03.063_bib19","first-page":"e20","article-title":"Ocular complications of hepatitis C treatment [in French] [report online]","volume":"30","author":"Sauer","year":"2007","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.ophtha.2010.03.063_bib20","first-page":"1303","article-title":"Dry cough and optic neuritis: two rare complications of interferon alpha treatment in chronic viral hepatitis [letter]","volume":"96","author":"Isler","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ophtha.2010.03.063_bib21","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/01.coc.0000227526.96319.50","article-title":"Ischemic optic neuropathy associated with low-dose interferon alfa: report of two cases","volume":"32","author":"Rodney","year":"2009","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ophtha.2010.03.063_bib22","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/00041327-200312000-00003","article-title":"Interferon-alpha-associated bilateral simultaneous ischemic optic neuropathy","volume":"23","author":"Vardizer","year":"2003","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.ophtha.2010.03.063_bib23","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0168-8278(02)00243-X","article-title":"Visual loss during interferon-alpha therapy in hepatitis C virus infection [letter]","volume":"37","author":"Perlemuter","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.ophtha.2010.03.063_bib24","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/00041327-200403000-00035","article-title":"Unilateral pallid optic disc swelling and anemia associated with interferon alpha treatment [letter]","volume":"24","author":"Foroozan","year":"2004","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.ophtha.2010.03.063_bib25","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0168-8278(05)80331-9","article-title":"Optic tract neuropathy complicating low-dose interferon treatment","volume":"21","author":"Manesis","year":"1994","journal-title":"J Hepatol"},{"key":"10.1016\/j.ophtha.2010.03.063_bib26","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/S0140-6736(99)00403-1","article-title":"Severe loss of vision during adjuvant interferon alfa-2b treatment for malignant melanoma [letter]","volume":"353","author":"Lohmann","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ophtha.2010.03.063_bib27","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1055\/s-0029-1220250","article-title":"Peripheral polyneuropathy and bilateral optic neuropathy during treatment of chronic hepatitis C [in German]","volume":"134","author":"Chrissafidou","year":"2009","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.ophtha.2010.03.063_bib28","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.gcb.2008.12.004","article-title":"Anterior ischemic optic neuropathy complicating interferon alpha and ribavirin therapy in patients with chronic hepatitis C","volume":"33","author":"Kabbaj","year":"2009","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.ophtha.2010.03.063_bib29","first-page":"16","article-title":"Serious loss of vision in bilateral anterior ischemic optic neuropathy caused by interferon [in Japanese]","volume":"113","author":"Kiuchi","year":"2009","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"10.1016\/j.ophtha.2010.03.063_bib30","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.2169\/internalmedicine.47.1401","article-title":"Optic neuritis caused by interferon-beta administration","volume":"47","author":"Okuma","year":"2008","journal-title":"Intern Med"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642010003829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642010003829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:00:12Z","timestamp":1758981612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642010003829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0161642010003829"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2010.03.063","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interferon Alfa-associated Anterior Ischemic Optic Neuropathy","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2010.03.063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}